Registration Strip Icon for discussion Inscrivez-vous pour interagir sur nos forums actifs pour discuter avec des investisseurs aux idées similaires.

TEVA

Teva Pharmaceutical Indu... (TEVA)

Teva Pharmaceutical Industries Ltd
De:
Trier par:
 Showing the most relevant articles for your search:NYSE:TEVA
DateHeureSourceTitreSymboleSociété
03/08/202213h11Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NYSE:TEVATeva Pharmaceutical Industries Ltd
02/08/202214h36TipRanksAnalysts’ Opinions Are Mixed on These Healthcare Stocks: Teva Pharmaceutical (TEVA), HUTCHMED (HCM) and Arcutis Biotherapeutics (ARQT)NYSE:TEVATeva Pharmaceutical Industries Ltd
29/07/202214h21TipRanksJ.P. Morgan Maintains Their Hold Rating on Teva Pharmaceutical (TEVA)NYSE:TEVATeva Pharmaceutical Industries Ltd
29/07/202213h05Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NYSE:TEVATeva Pharmaceutical Industries Ltd
27/07/202222h07Edgar (US Regulatory)Quarterly Report (10-q)NYSE:TEVATeva Pharmaceutical Industries Ltd
27/07/202216h21TipRanksHere’s Why Teva Shares are Trending Higher TodayNYSE:TEVATeva Pharmaceutical Industries Ltd
27/07/202213h31TipRanksThese Stocks Are the Biggest Pre-Market Movers on WednesdayNYSE:TEVATeva Pharmaceutical Industries Ltd
26/07/202223h53Dow Jones NewsTeva Pharma ADRs Jump 17% On Pending Nationwide Agreement Over Opioid LitigationNYSE:TEVATeva Pharmaceutical Industries Ltd
26/07/202222h55Business WireTeva Reports Second Quarter 2022 Financial ResultsNYSE:TEVATeva Pharmaceutical Industries Ltd
25/07/202214h00GlobeNewswire Inc.Certara Appoints Rosemary Crane as New Independent Board MemberNYSE:TEVATeva Pharmaceutical Industries Ltd
13/07/202215h53PR Newswire (US)Teva Pharmaceuticals accredited Migraine Friendly Workplace StampNYSE:TEVATeva Pharmaceutical Industries Ltd
12/07/202223h05Dow Jones NewsADRs End Lower; Teva Pharmaceutical, Banco Santander Trade ActivelyNYSE:TEVATeva Pharmaceutical Industries Ltd
12/07/202218h39Dow Jones NewsTeva Pharmaceutical, Abbvie's Allergan Settle Opioid Suit With San Francisco -- UpdateNYSE:TEVATeva Pharmaceutical Industries Ltd
12/07/202217h38Dow Jones NewsTeva Pharmaceutical, Abbvie's Allergan Settle Opioid Suit With San FranciscoNYSE:TEVATeva Pharmaceutical Industries Ltd
12/07/202216h30Business WireTeva Reaches Agreement With San Francisco to Settle Opioid-Related ClaimsNYSE:TEVATeva Pharmaceutical Industries Ltd
11/07/202217h11Dow Jones NewsNew York Attorney General Seeks to Bring Teva Back Into Opioid Case -- UpdateNYSE:TEVATeva Pharmaceutical Industries Ltd
11/07/202216h31Dow Jones NewsNew York Attorney General Seeks to Bring Teva Back Into Opioid CaseNYSE:TEVATeva Pharmaceutical Industries Ltd
05/07/202214h56Dow Jones NewsAgilent: FDA Approves Teva's Content Uniformity Method Using TRS100 SystemNYSE:TEVATeva Pharmaceutical Industries Ltd
01/07/202214h34Business WireTeva Announces Appointment of New Global R&D and Chief Medical OfficerNYSE:TEVATeva Pharmaceutical Industries Ltd
29/06/202222h09Business WireTeva to Host Conference Call to Discuss Second Quarter 2022 Financial Results at 8 a.m. ET on July 27, 2022NYSE:TEVATeva Pharmaceutical Industries Ltd
26/06/202202h45Business WireTeva veröffentlicht vielversprechende Zwischenergebnisse der PEARL-Studie zur Wirksamkeit von AJOVY® (Fremanezumab)NYSE:TEVATeva Pharmaceutical Industries Ltd
25/06/202218h16Business WireTeva annonce des résultats provisoires prometteurs de son étude PEARL concernant l’impact d’AJOVY® (frémanezumab)NYSE:TEVATeva Pharmaceutical Industries Ltd
24/06/202218h54Business WireTeva Announces Promising Interim Results From Its Study PEARL, About the Impact of AJOVY® (fremanezumab)NYSE:TEVATeva Pharmaceutical Industries Ltd
23/06/202222h03Edgar (US Regulatory)Current Report Filing (8-k)NYSE:TEVATeva Pharmaceutical Industries Ltd
09/06/202223h15Business WireTeva Announces Settlement with Aurobindo Resolving AUSTEDO® (deutetrabenazine) Patent DisputeNYSE:TEVATeva Pharmaceutical Industries Ltd
09/06/202214h00Business WireNew Real-World Data Evaluating AJOVY® (fremanezumab-vfrm) Injection Use in Patients With Migraine Presented at 2022 American Headache Society Annual MeetingNYSE:TEVATeva Pharmaceutical Industries Ltd
09/06/202213h45Business WireTeva to Present Latest Data on AJOVY® (fremanezumab-vfrm) Injection at the 2022 American Headache Society Annual MeetingNYSE:TEVATeva Pharmaceutical Industries Ltd
08/06/202215h00Business WireDirect Relief, the National Association of Free and Charitable Clinics and Teva Pharmaceuticals Partner to Advance Access to Behavioral Health ServicesNYSE:TEVATeva Pharmaceutical Industries Ltd
25/05/202216h38Dow Jones NewsTeva Pharmaceutical Settles Opioid Suit With West VirginiaNYSE:TEVATeva Pharmaceutical Industries Ltd
25/05/202215h36Business WireTeva Reaches Agreement With West Virginia to Settle the State’s Opioid-Related ClaimsNYSE:TEVATeva Pharmaceutical Industries Ltd
 Showing the most relevant articles for your search:NYSE:TEVA